Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease [Letter]

Yanli Guo1 Yuncheng Vocational and Technical University, Yuncheng, Shanxi, 044000, People’s Republic of China

Yuechou Nong2 Department of Endocrinology and Metabolism, The Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530021, People’s Republic of ChinaCorrespondence[email protected]

References

Li X, Wang Z, Zhu Y, et al. Prognostic value of fibrinogen-to-albumin ratio in coronary three-vessel disease. J Inflamm Res. 2023;16:5767–5777. doi:10.2147/JIR.S443282
PubMed Web of Science ®Google Scholar
International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(5):385–396. doi:10.1016/S2213-8587(18)30315-2
PubMed Web of Science ®Google Scholar
Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753–2786. doi:10.2337/dci22-0034
PubMed Web of Science ®Google Scholar
Jabbar A, Pingitore A, Pearce SHS, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39–55. doi:10.1038/nrcardio.2016.174
PubMed Web of Science ®Google Scholar

Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease [Letter]

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease [Letter]

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date